Teleflex Incorporated
TFX
Classement en actions
#3216
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Prix de l'action
$131.01
Capitalisation boursière
$5.55B
Changement (1 jour)
1.10%
Changement (1 an)
0.36%
Pays
US
Échange Teleflex Incorporated (TFX)
Catégorie
Healthcare
Ratio P/E pour Teleflex Incorporated (TFX)
Ratio P/E au October 2026 TTM : -5.30
Selon les derniers rapports financiers et le cours de l'action de Teleflex Incorporated, le ratio P/E actuel (TTM) est de -5.30. À la fin de l’année 2023, le P/E de l’entreprise était de 32.87.
Historique du ratio P/E pour Teleflex Incorporated de 2000 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | -5.30 | -104.43% |
| 2024 | 119.64 | 263.93% |
| 2023 | 32.87 | 1.97% |
| 2022 | 32.24 | 1.85% |
| 2021 | 31.65 | -44.52% |
| 2020 | 57.06 | 51.40% |
| 2019 | 37.69 | -35.92% |
| 2018 | 58.81 | -19.89% |
| 2017 | 73.41 | 149.60% |
| 2016 | 29.41 | 31.84% |
| 2015 | 22.31 | -11.85% |
| 2014 | 25.31 | -1.03% |
| 2013 | 25.57 | -266.80% |
| 2012 | -15.33 | -299.68% |
| 2011 | 7.68 | -28.10% |
| 2010 | 10.68 | 51.16% |
| 2009 | 7.06 | -57.34% |
| 2008 | 16.56 | -1.95% |
| 2007 | 16.89 | -8.27% |
| 2006 | 18.41 | -3.49% |
| 2005 | 19.08 | -91.25% |
| 2004 | 218.11 | 1,134.01% |
| 2003 | 17.68 | 32.21% |
| 2002 | 13.37 | -18.05% |
| 2001 | 16.31 | 5.58% |
| 2000 | 15.45 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 47.48 | -996.61% |
US
|
|
| 27.43 | -617.86% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -1,174.29% |
US
|
|
| - | - |
CH
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.